Brain histamine H₁ receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine

Bibliography

• Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009;64:1427-43
   PubMed Web of Science ®Google Scholar
• Church MK, Maurer M, Simons FE, et al. Risk of first-generation H1-antihistamines: a GA(2)LEN position paper. Allergy 2010;65:459-66
   PubMed Web of Science ®Google Scholar
• Yanai K, Rogala B, Chugh K, et al. Safety considerations in the management of allergic diseases: focus on antihistamines. Curr Med Res Opin 2012;28:623-42
   PubMed Web of Science ®Google Scholar
• Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-30
   PubMed Web of Science ®Google Scholar
• Broccatelli F, Carosati E, Cruciani G, et al. Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target. Mol Inform 2010;29:16-26
   PubMed Web of Science ®Google Scholar
• Broccatelli F, Larregieu CA, Cruciani G, et al. Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev 2012;64:95-109
   PubMed Web of Science ®Google Scholar
• Chen C. Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine. Curr Med Chem 2008;15:2173-91
   PubMed Web of Science ®Google Scholar
• Chishty M, Reichel A, Siva J, et al. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines. J Drug Target 2001;9:223-8
   PubMed Web of Science ®Google Scholar
• Uesawa Y, Hishinuma S, Shoji M. Molecular determinants responsible for sedative and non-sedative properties of histamine H1-receptor antagonists. J Pharmacol Sci 2014;124:160-8
   PubMed Web of Science ®Google Scholar
• Mahar Doan KM, Wring SA, Shampine LJ, et al. Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding. Pharmacology 2004;72:92-8
   PubMed Web of Science ®Google Scholar
• Inoue I, Yanai K, Kitamura D, et al. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 1996;93:13316-20
   PubMed Web of Science ®Google Scholar
• Shimamura T, Shiroishi M, Weyand S, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011;475:65-70
   PubMed Web of Science ®Google Scholar
• Yanai K, Ryu JH, Watanabe T, et al. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br J Pharmacol 1995;116:1649-55
   PubMed Web of Science ®Google Scholar
• Tashiro M, Duan X, Kato M, et al. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin. Br J Clin Pharmacol 2008;65:811-21
   PubMed Web of Science ®Google Scholar
• Tashiro M, Kato M, Miyake M, et al. Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin. Hum Psychopharmacol 2009;24:540-8
   PubMed Web of Science ®Google Scholar
• Tashiro M, Mochizuki H, Sakurada Y, et al. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with 11C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen. Br J Clin Pharmacol 2006;61:16-26
   PubMed Web of Science ®Google Scholar
• Tashiro M, Sakurada Y, Iwabuchi K, et al. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. J Clin Pharmacol 2004;44:890-900
   PubMed Web of Science ®Google Scholar
• Shamsi Z, Hindmarch I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 2000;15:S3-S30
   PubMed Web of Science ®Google Scholar
• McDonald K, Trick L, Boyle J. Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 2008;23:555-70
   PubMed Web of Science ®Google Scholar
• Kubo N, Senda M, Ohsumi Y, et al. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio. Hum Psychopharmacol 2011;26:133-9
   PubMed Web of Science ®Google Scholar
• Yanai K, Zhang D, Tashiro M, et al. Positron emission tomography evaluation of sedative properties of antihistamines. Expert Opin Drug Saf 2011;10:613-22
   PubMed Web of Science ®Google Scholar
• Gillard M, Van Der Perren C, Moguilevsky N, et al. Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol 2002;61:391-9
   PubMed Web of Science ®Google Scholar
• Grant JA, Riethuisen JM, Moulaert B, et al. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol 2002;88:190-7
   PubMed Web of Science ®Google Scholar
• Schoepke N, Church MK, Maurer M. The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers. Acta Derm Venereol 2013;93:286-93
   PubMed Web of Science ®Google Scholar
• Devalia JL, De Vos C, Hanotte F, et al. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 2001;56:50-7
   PubMed Web of Science ®Google Scholar
• Verster JC, de Weert AM, Bijtjes SI, et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2003;169:84-90
   PubMed Web of Science ®Google Scholar
• De Vos C, Mitchev K, Pinelli ME, et al. Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clin Drug Investig 2008;28:221-30
   PubMed Web of Science ®Google Scholar
• Tzanetos DB, Fahrenholz JM, Scott T, et al. Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial. Ann Allergy Asthma Immunol 2011;107:517-22
   PubMed Web of Science ®Google Scholar
• Holgate ST, Canonica GW, Simons FE, et al. Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003;33:1305-24
   PubMed Web of Science ®Google Scholar
• Okamura N, Yanai K, Higuchi M, et al. Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br J Pharmacol 2000;129:115-23
   PubMed Web of Science ®Google Scholar
• Tagawa M, Kano M, Okamura N, et al. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. Br J Clin Pharmacol 2002;53:296-304
   PubMed Web of Science ®Google Scholar
• Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 2002;32:133-9
   PubMed Web of Science ®Google Scholar
• Tashiro M, Horikawa E, Mochizuki H, et al. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. Hum Psychopharmacol 2005;20:501-9
   PubMed Web of Science ®Google Scholar
• Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int 2007;165:216-24
   PubMed Web of Science ®Google Scholar
• Peters FT HM, Herbold M, Schmitt G, et al. Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen - Anforderungen and die Validierung von Analysenmethoden. Toxichem Krimtech 2009;76:185-208
   Google Scholar
• Iwata R, Pascali C, Bogni A, et al. A simple loop method for the automated preparation of 11C-raclopride from 11C-methyl triflate. Appl Radiat Isot 2001;55:17-22
   PubMed Web of Science ®Google Scholar
• Mochizuki H. Quantitative measurement of histamine H1 receptors in human brains by PET and [11C]doxepin. Nucl Med Biol 2004;31:165-71
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Watanuki S, Yamamoto S, et al. Performance evaluation of a large axial field-of-view PET scanner: SET-2400W. Ann Nucl Med 1997;11:307-13
   PubMedGoogle Scholar
• Mochizuki H, Kimura Y, Ishii K, et al. Simplified PET measurement for evaluating histamine H1 receptors in human brains using [11C]doxepin. Nucl Med Biol 2004;31:1005-11
   PubMed Web of Science ®Google Scholar
• Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003;19:224-47
   PubMed Web of Science ®Google Scholar
• Zhang D, Tashiro M, Shibuya K, et al. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography. J Clin Psychopharmacol 2010;30:694-701
   PubMed Web of Science ®Google Scholar
• Tagawa M, Kano M, Okamura N, et al. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 2001;52:501-9
   PubMed Web of Science ®Google Scholar
• Yanai K, Ryu JH, Watanabe T, et al. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine. Methods Find Exp Clin Pharmacol 1995;17(Suppl C):64-9
   PubMedGoogle Scholar
• Shibuya K, Funaki Y, Hiraoka K, et al. [11C]Doxepin binding to histamine H1 receptors in living human brain: reproducibility during attentive waking and circadian rhythm. Front Syst Neurosci 2012;6:45
   PubMedGoogle Scholar
• Farré M, Pérez-Mañá C, Papaseit E, et al. Bilastine vs. hydroxyzine: occupation of brain histamine H1 receptors evaluated by positron emission tomography in healthy volunteers. Br J Clin Pharmacol 2014;78:970-80
   PubMed Web of Science ®Google Scholar
• Gupta A, Chatelain P, Massingham R, et al. Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu). Drug Metab Dispos 2006;34:318-23
   PubMed Web of Science ®Google Scholar
• Gupta A, Hammarlund-Udenaes M, Chatelain P, et al. Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding. Biopharm Drug Dispos 2006;27:291-7
   PubMed Web of Science ®Google Scholar